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In this issue of Cell, Lee et al. (2006) report that the parasite Trypanosoma brucei synthesizes 
fatty acids in an unconventional way. T. brucei and two other trypanosomes use enzymes 
called elongases to synthesize myristate, a fourteen carbon (C14) fatty acid essential for 
pathogenesis. This is an unexpected finding as these enzymes were thought only to elon-
gate already long (C16 or C18) acyl chains.Fatty acid synthesis is particularly 
important in the pathogenesis of 
Trypanosoma brucei, the parasite 
that is transmitted by the tsetse fly 
and causes sleeping sickness in 
humans. T. brucei—in addition to 
the usual requirement of fatty acids 
for making cellular membranes—
needs large amounts of myristate, 
a fourteen carbon (C14) fatty acid, 
to evade the immune system of the 
mammalian host. In the mammalian 
bloodstream, T. brucei survives the 
host immune system by switching 
surface coats composed of about 
107 copies of variant surface glyco-
protein (VSG) molecules of which 
T. brucei encodes about 1000 spe-
cies. Each VSG is attached to the 
plasma membrane of the parasite 
by a glycosylphosphatidylinositol 
(GPI) anchor. Strikingly, the fatty 
acid chains of the GPI anchor con-
sist exclusively of myristate (Fer-
guson et al., 1985). This unique 
composition renders the organism 
extremely sensitive to myristate 
analogs (Doering et al., 1994). 
Interestingly, the form of T. brucei 
that lives in the midgut of the tsetse 
fly lacks VSGs. Therefore, once an 
infected fly bites a mammal trans-
ferring the trypanosome in the 
process, the parasite must quickly 
make or obtain myristate to anchor 
its protective VSG surface coat. 
The source of myristate was a long-
standing mystery as blood contains 
little myristate, and it was thought 
that bloodstream trypanosomes were unable to synthesize fatty 
acids (Paul et al., 2001). Although 
T. brucei efficiently scavenges myr-
istate from host blood and channels 
it into VSG anchors, the supply is 
insufficient to account for the den-
sity of parasites observed in blood 
(Paul et al., 2001). The solution to 
this conundrum was the seren-
dipitous finding that T. brucei spe-
cifically elongates laurate, a twelve 
carbon fatty acid, to myristate in 
vivo (Morita and Englund, 2001). 
Furthermore, in vitro experiments Cell 126, Ademonstrated the efficient elonga-
tion of butyryl-CoA (a four carbon 
primer) to myristate that could then 
be attached to VSG anchors. In this 
issue of Cell, Lee et al. (2006) iden-
tify the enzymes that perform this 
reaction.
The bulk of fatty acid synthesis in 
mammalian cells and fungi occurs 
in the cytosol using fatty acid 
megasynthases in which each of 
the required enzyme active sites is 
present within one or two very large 
proteins (these are called type I sys-Figure 1. Comparisons of Known Fatty Acid Synthesis Systems with each other and 
with the Elongase System of T. brucei
The abbreviations are KS, 3-ketoacyl synthase; KR, 3-ketoacyl reductase; DH, 3-hydroxyacyl 
dehydratase; ER, enoyl reductase; MAT, malonyl-CoA:ACP transacylase; and ACP, acyl carrier 
protein. Enzymatic steps common to all three pathways are in blue whereas those proteins that 
act only in the conventional fatty acid synthesis pathways are in black. The mammalian type I 
system exists as a megasynthase complex in which the activating thiol and the elongation donor 
exist as domains of the megasynthase. In the type II system and in T. brucei, the enzymatic activi-
ties are part of individual proteins. The sequences of the proteins catalyzing a given enzymatic 
step are not necessarily conserved. A variety of proteins that possess 3-ketoacyl synthase, enoyl 
reductase, or 3-hydroxyacyl dehydratase activities are found in nature.ugust 25, 2006 ©2006 Elsevier Inc. 641
tems) (Cronan, 2006). In plants, fatty 
acid synthesis until the C18 stage is 
performed in the chloroplasts using 
a series of small discrete soluble 
proteins, each responsible for one 
reaction of the cycle (called a type 
II system). This system is derived 
from the ancestral cyanobacterium 
endosymbiont and strongly resem-
bles that seen in bacteria (Campbell 
and Cronan, 2001). Another type 
of compartmentalization is seen in 
the apicomplexan protozoa (exem-
plified by the parasites that cause 
malaria and toxoplasmosis) where 
the responsible type II system lies 
within an organelle thought to be a 
remnant from the engulfment of an 
algal cell (Sonda and Hehl, 2006). 
Finally, eukaryotes have a mitochon-
drial type II system. However, the 
mitochondrial pathway is of very low 
synthetic capacity and is thought to 
be involved in making lipoic acid for 
the TCA cycle (Cronan et al., 2005). 
A key characteristic of both types of 
fatty acid synthetic systems is that 
they require a protein that is cova-
lently modified by attachment of a 
4′-phosphopantetheine (the non-
nucleotide portion of CoA). In type 
II systems the modified protein is 
called acyl carrier protein (ACP) 
because all of the intermediates of 
fatty acid synthesis are linked to the 
thiol of the prosthetic group (Camp-
bell and Cronan, 2001). The ACPs of 
type I systems are discrete domains 
of the polyfunctional proteins (Cro-
nan, 2006). In Figure 1 the proper-
ties of the fatty acid synthetic sys-
tems are compared and contrasted 
with that discovered by Lee and 
coworkers (Lee et al., 2006).
Given that the butyryl-CoA elon-
gation system in T. brucei appeared 
to be membrane bound rather than 
cytosolic and that an inhibitor of 
type II fatty acid synthesis inhib-
ited T. brucei in vitro fatty acid syn-
thesis, it seemed possible that the 
synthesis observed by Morita et al. 
(Morita and Englund, 2001; Morita 
et al., 2000) was due to contamina-
tion of the T. brucei membrane frac-
tion with an unrecognized organelle 
that contained a type II system. 
However, Lee and coworkers (2006) 642 Cell 126, August 25, 2006 ©2006 Elshave clearly shown this to be incor-
rect. Instead T. brucei “cheats” 
by using elongation enzymes to 
make myristate (a relatively short 
chain fatty acid). This is a surprise 
because elongases are normally 
used to extend long chain fatty 
acids (e.g., extend C18 to C26). 
Hence, T. brucei uses what would 
be called a type III system except 
that the responsible enzymes are 
homologs of the well-characterized 
elongase enzymes of mammals and 
yeast.
Lee et al. (2006) focused on the 
T. brucei elongase pathway for sev-
eral reasons. First, the membrane 
localization of myristate produc-
tion seemed to preclude involve-
ment of a type I megasynthase 
(Morita and Englund, 2001; Morita 
et al., 2000). This was confirmed 
by the recently completed T. brucei 
genome sequence in which no genes 
encoding a type I megasynthase are 
present. However, the genome does 
include four candidate genes that are 
homologous to the ELO genes known 
to encode microsomal elongase 
enzymes in vertebrates and in yeast. 
Taken together these data suggested 
that fatty acid synthesis in T. brucei 
proceeds by an elongase mecha-
nism. To eliminate the possibility of an 
organellar type II system, the authors 
efficiently reduced the expression of 
the key ACP component of the type 
II system using RNA interference 
(RNAi). This had no effect on myr-
istate synthesis assayed in vitro. In 
contrast, a quantitatively less impres-
sive knockdown of ELO1 expression 
almost completely blocked myristate 
synthesis. The authors then went on 
to construct genomic deletion muta-
tions of each of the four ELO genes. 
Using membrane preparations 
derived from these deletion mutants, 
the synthesis of myristate was shown 
to require both ELO1 and ELO2 with 
the former enzyme being responsi-
ble for elongation of the C4 primer 
to C10 whereas the latter enzyme 
catalyzes the last two C2 additions 
to give myristate. ELO3 elongates 
myristoyl-CoA to C16 and C18 and 
thus seems to work at crosspur-
poses to myristate production. How-evier Inc.ever, in vivo ELO3 would presumably 
be competing for myristoyl-CoA with 
the enzymes catalyzing transfer of 
myristate into glycosylphosphatidyli-
nositol anchors, or this enzyme could 
be downregulated. ELO4 seems 
completely unconnected from myr-
istate production in that it elongates 
arachidonoyl-CoA to a C22 polyun-
saturated species.
Several major questions remain. 
First, does an ELO2 mutant strain 
accumulate VSGs anchored by 
GPIs with abnormally short fatty 
acids? If so, the VSGs tethered by 
these anchors must be functional in 
evading host immunity because the 
ELO mutant strains remain patho-
genic (Lee et al., 2006). Second, 
what is the source of the butyryl-
CoA primer? Although butyrate pro-
duced by gut microbes is present 
in blood, T. brucei seems unable to 
assimilate this acid (Morita et al., 
2000). Hence, production by catab-
olism of some molecule abundant 
in blood seems more likely. Third, 
is this elongation pathway used by 
the organism to make membrane 
lipid acyl chains? This seems to be 
the case in the tsetse fly form of T. 
brucei because RNAi knockdown of 
expression of a microsomal enoyl 
reductase homolog prevented 
growth of the parasite (Lee et al., 
2006). However, this may not be the 
case for the blood form because it 
dwells in a very lipid-rich environ-
ment. Finally, the pathway appears 
regulated by the lipid content of 
the medium at least in the tsetse 
fly form of the parasite (Lee et al., 
2006). Given that the use of elon-
gases in synthesizing fatty acids is 
conserved among trypanosomes 
(Lee et al., 2006), this study has sig-
nificantly widened our understand-
ing of the mechanisms of fatty acid 
synthesis.
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process that drives morphogenesis 
during development. For example, 
in the Drosophila embryo, constric-
tion of the apical epithelial surface 
during gastrulation results in invagi-
nation (Figure 1A), whereas more 
complex cell shape changes give 
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tion. In a recent study in Nature, 
Gibson et al. (2006) address this 
question in the proliferating wing-
disc epithelium of Drosophila.
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nal cell shape is not simply a con-
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(see Figure 1). In the fly embryo, 
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